Back to Blog
ITCOctober 28, 2026·337-TA-3943·SUPPLEMENTAL COMPLAINT FILED

Certain Spectral Flow Cytometry Systems and Components Thereof; Inv. No. 337-TA-3943 (Violation)

U.S. International Trade Commission

Holding

This supplemental complaint, a cover-letter First Supplement filed by Cytek Biosciences, Inc., submits USPTO-certified copies of the patents, assignment documents and prosecution histories for the asserted '128, '167 and '245 patents in the investigation of Certain Spectral Flow Cytometry Systems and Components Thereof.

Why It Matters

The filing supplies certified copies of the patent records required by the Commission rules, replacing the uncertified copies filed with the October 8, 2026 verified complaint. It adds no new allegations, accused products or relief; the text states nothing about the exclusion order sought or the market impact.

Full Summary

This supplemental complaint, a cover-letter First Supplement filed by Cytek Biosciences, Inc., submits USPTO-certified copies of the patents, assignment documents and prosecution histories for the asserted '128, '167 and '245 patents in the investigation of Certain Spectral Flow Cytometry Systems and Components Thereof. The filing supplies certified copies of the patent records required by the Commission rules, replacing the uncertified copies filed with the October 8, 2026 verified complaint. It adds no new allegations, accused products or relief; the text states nothing about the exclusion order sought or the market impact. Complainant is Cytek Biosciences, Inc., represented by Stephen R. Smith of Cooley LLP; respondents are not identified in the document. Asserted patents are U.S. Patent Nos. 12,754,128, 12,487,167 and 10,739,245. Exhibits 1-3 are certified copies of the three patents under Rule 210.12(a)(9)(i). Exhibits 4-6 are certified assignment documents under Rule 210.12(a)(9)(ii). Appendices A-C are certified prosecution histories under Rule 210.12(c)(1). The document does not discuss accused products, domestic industry or the relief sought.

Key Points

  • Complainant is Cytek Biosciences, Inc., represented by Stephen R. Smith of Cooley LLP; respondents are not identified in the document.
  • Asserted patents are U.S. Patent Nos. 12,754,128, 12,487,167 and 10,739,245.
  • Exhibits 1-3 are certified copies of the three patents under Rule 210.12(a)(9)(i).
  • Exhibits 4-6 are certified assignment documents under Rule 210.12(a)(9)(ii).
  • Appendices A-C are certified prosecution histories under Rule 210.12(c)(1).
  • The document does not discuss accused products, domestic industry or the relief sought.
amended complaint

How this summary was made: Drafted with AI from the Commission's document; before publishing, code checked that the quotation and the citations it gives appear in that document. Editorial policy

More on this topic

New to ITC Section 337? Start with Certain Ink Cartridges I (Inv. No. 337-TA-1451): What It Changes for ITC Section 337